WAM
GILD icon

Worth Asset Management’s Gilead Sciences GILD Stock Holding History

Worth Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,589
Closed -$1.63M – 157
2025
Q1 		$1.63M Buy
14,589
+5,626
+63% +$581K 0.89% 27
2024
Q4 		$828K Sell
8,963
-15,111
-63% -$1.36M 0.44% 50
2024
Q3 		$2.02M Buy
+24,074
New +$1.84M 1.1% 22
2023
Q2 		– Sell
-913
Closed -$75.8K – 486
2023
Q1 		$75.8K Buy
913
+88
+11% +$7.29K 0.06% 151
2022
Q4 		$70.8K Buy
825
+645
+358% +$51.1K 0.05% 156
2022
Q3 		$11K Sell
180
-20,690
-99% -$1.3M 0.01% 265
2022
Q2 		$1.29M Buy
+20,870
New +$1.29M 0.88% 23

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Worth Asset Management's GILD Position: Q2 2025 in Review

Worth Asset Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 14,589 shares — an estimated $1.63M sold.

Worth Asset Management first reported a position in GILD in Q2 2022 and held it in 7 quarters. The position peaked at $2.02M in Q3 2024. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Worth Asset Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Worth Asset Management sold 14,589 Gilead Sciences shares in Q2 2025, an estimated $1.63M.
  • Worth Asset Management first reported a position in Gilead Sciences in Q2 2022 and held it in 7 quarters.
  • Worth Asset Management's Gilead Sciences position peaked at $2.02M in Q3 2024.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Worth Asset Management's 13F filing for Q2 2025, filed 10 Jul 2025.